The Japanese clinical practice guideline for acute kidney injury 2016

The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee

doi:10.1007/s10157-018-1600-4

The Japanese clinical practice guideline for acute kidney injury 2016

The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention is necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.

Original language	English
Pages (from-to)	985-1045
Number of pages	61
Journal	Clinical and Experimental Nephrology
Volume	22
Issue number	5
DOIs	https://doi.org/10.1007/s10157-018-1600-4
Publication status	Published - 01-10-2018

All Science Journal Classification (ASJC) codes

Physiology
Nephrology
Physiology (medical)

Access to Document

10.1007/s10157-018-1600-4

Cite this

@article{b308aeb129f14089a5052d9b0d894342,

title = "The Japanese clinical practice guideline for acute kidney injury 2016",

abstract = "Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention is necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.",

keywords = "Acute kidney injury, Atrial natriuretic peptide, Biomarker, Blood purification, Long-term follow-up, Nafamostat mesilate",

author = "{The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee} and Kent Doi and Osamu Nishida and Takashi Shigematsu and Tomohito Sadahiro and Noritomo Itami and Kunitoshi Iseki and Yukio Yuzawa and Hirokazu Okada and Daisuke Koya and Hideyasu Kiyomoto and Yugo Shibagaki and Kenichi Matsuda and Akihiko Kato and Terumasa Hayashi and Tomonari Ogawa and Tatsuo Tsukamoto and Eisei Noiri and Shigeo Negi and Koichi Kamei and Hirotsugu Kitayama and Naoki Kashihara and Toshiki Moriyama and Yoshio Terada",

note = "Publisher Copyright: {\textcopyright} 2018, The Author(s).",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s10157-018-1600-4",

language = "English",

volume = "22",

pages = "985--1045",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - The Japanese clinical practice guideline for acute kidney injury 2016

AU - The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee

AU - Doi, Kent

AU - Nishida, Osamu

AU - Shigematsu, Takashi

AU - Sadahiro, Tomohito

AU - Itami, Noritomo

AU - Iseki, Kunitoshi

AU - Yuzawa, Yukio

AU - Okada, Hirokazu

AU - Koya, Daisuke

AU - Kiyomoto, Hideyasu

AU - Shibagaki, Yugo

AU - Matsuda, Kenichi

AU - Kato, Akihiko

AU - Hayashi, Terumasa

AU - Ogawa, Tomonari

AU - Tsukamoto, Tatsuo

AU - Noiri, Eisei

AU - Negi, Shigeo

AU - Kamei, Koichi

AU - Kitayama, Hirotsugu

AU - Kashihara, Naoki

AU - Moriyama, Toshiki

AU - Terada, Yoshio

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention is necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.

AB - Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention is necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.

KW - Acute kidney injury

KW - Atrial natriuretic peptide

KW - Biomarker

KW - Blood purification

KW - Long-term follow-up

KW - Nafamostat mesilate

UR - http://www.scopus.com/inward/record.url?scp=85050557338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050557338&partnerID=8YFLogxK

U2 - 10.1007/s10157-018-1600-4

DO - 10.1007/s10157-018-1600-4

M3 - Article

C2 - 30039479

AN - SCOPUS:85050557338

SN - 1342-1751

VL - 22

SP - 985

EP - 1045

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

IS - 5

ER -

The Japanese clinical practice guideline for acute kidney injury 2016

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this